Skip to content

Have no Fear, Treatment Guidance for Antimicrobial Resistant Gram-Negative Infections is Here: A guideline-based approach to management of infections caused by ESBL-E

This activity is intended for pharmacists focused on the research and treatment of infectious disease.

Extended-spectrum beta-lactamase producing Enterobacterales (ESBL-E) have become an increasing threat in both community and hospital-acquired infections. The Infectious Diseases Society of America (IDSA) released the first consensus guidance document on management of these serious infections in 2020. This presentation will apply guidance from the IDSA to the appropriate management of patients who have infections with ESBL-E.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Recall changes in predominant ESBL enzymes and screening that have shaped the way in which these organisms are treated
  • Define the IDSA treatment recommendations for infections caused by ESBL-E
  • Recognize clinical trials that have contributed to the current understanding of managing ESBL-E

Presenter

Taylor Hodle, PharmD is a PGY2 critical care pharmacy resident at Baystate Medical Center in Springfield, MA. Prior to residency, she received her doctorate of pharmacy from the Wilkes University Nesbitt School of Pharmacy in Wilkes-Barre, PA. After completion of her PGY2 residency, Taylor will be continuing her career at Baystate Medical Center as a clinical pharmacist. Her practice interests include trauma/cardiothoracic critical care and academia.

Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.

Register


ACPE logo

Release Date: June 3, 2021
Expiration Date: June 3 2022
Contact Hours: 1 (.10 CEU)
Universal Activity Number: 0026-0000-21-132-H01-P | Knowledge-based
ACPE Topic Designator: Drug Therapy

Accreditation

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1 contact hours (0.1 CEUs).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-test, and evaluation. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

It is the policy of MCPHS-CE to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All individuals engaged in the planning of a continuing education activity and who are in a position to control the educational content are required to disclose any financial relationships with ineligible companies occurring within the past 24 months. The intent of this policy is to identify and mitigate any potential conflict of interest that may directly or indirectly affect the activity. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

MCPHS will identify, review and mitigate all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

No funding from industry provided for this event. No exhibitors will be present.
Taylor Hodle and MCPHS CE staff members hold no financial relationships with ineligible companies, related to the content of this presentation.